beliefs

GPOPPLUS (GPOX:US:OTC) Announces Impressive Revenue Results

Source Node:
Time Stamp: August 1, 2023 5:58 AM - Modified On: August 1, 2023 - Published By:
Source Cluster:
Republished By Plato

GPOPlus+, (GPOX:US:OTC) a leading provider and distributor of products for convenience stores and specialty retailers, gas stations, smoke shops, has recently announced an impressive surge in revenues during the fourth quarter of the year. The company reported a staggering 320% increase in its financial performance, marking a significant milestone for the organization. GPOPlus+ offers a unique technology driven direct store delivery model (“DSD”) that is creating both significant increases in revenue as well as improved unit economics with greater efficiencies yielding higher margins.  The Company has implemented this program successfully

Crypto’s Moment of Truth

Source Node:
Time Stamp: July 1, 2023 9:27 AM - Modified On: July 1, 2023 - Published By:
Source Cluster:
Republished By Plato

In a pivotal moment for crypto, recent news that BlackRock and others such as Fidelity have filed for spot Bitcoin ETFs propelled BTC to a yearly high of just under $31,700. What does the arrival of these significant players mean for the future of crypto? For years, the prospect of a Bitcoin ETF approval in the United States has been shrouded in uncertainty. However, the tides are turning this time, as the involvement of industry giants like BlackRock hints at a higher likelihood of approval. Deniz, our CEO, echoes this

BREATHE! Convention Charts New Territory with World’s Largest Communal NFT

Source Node:
Time Stamp: June 19, 2023 5:32 AM - Modified On: June 19, 2023 - Published By:
Source Cluster:
Republished By Plato

For Immediate Release June 19, 2023 LAS VEGAS, NV - BREATHE! Convention, a leading event in the emerging tech space, proudly announces a groundbreaking endeavor to set a new Guinness World Record with the creation of the World’s Largest Communal NFT, during its upcoming convention in Las Vegas from September 13 to 15, 2023. At the heart of this year's convention is a monumental collaborative art project spearheaded by tech industry veteran and creative thinker, Aaron Vick. Known for his innovative digital art pieces, Aaron Vick will facilitate the creation

Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimer’s Disease.

Source Node:
Time Stamp: June 7, 2023 12:22 PM - Modified On: June 7, 2023 - Published By:
Source Cluster:
Republished By Plato

Highlights Coya reports new data illustrating that administration of COYA 301 (low dose Interleukin-2 (IL-2)) in an open- label study in 8 patients with mild to moderate AD (COYA 301 Trial) resulted in a statistically significant reduction in the expression of three well characterized proinflammatory cytokines -- Tumor Necrosis Factor alpha (TNF-α), Interleukin 6 (IL-6), and Interleukin 1- Beta (IL-1β) -- which correlated with lack of cognitive decline of the patients over the course of the study. TNF-α is one of the main inflammatory cytokines involved in initiating and propagating